New TB cocktails show promise in early trial
NCT ID NCT05382312
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 37 times
Summary
This study tested new combinations of tuberculosis (TB) drugs in 127 adults with drug-sensitive TB. Participants received one of several two-drug combinations or standard care for 14 days, then switched to standard treatment. The goal was to see how quickly the drugs killed TB bacteria and if they were safe. Results help identify promising combos for future shorter TB treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
GSK Investigational Site
Bellville, 7530, South Africa
Conditions
Explore the condition pages connected to this study.